Lundbeck Expands CNS Franchise with US$2 B Alder Acquisition
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 9 (Table of Contents)
Published: 19 Sep-2019
DOI: 10.3833/pdr.v2019.i9.2458 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
As it faces pressure from upcoming patent expirations and generic competition, Lundbeck has agreed to acquire Alder BioPharmaceuticals to diversify its CNS franchise...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS